Advertisement

Topics

Capricor to continue trials of DMD treatment

05:12 EDT 31 Jul 2017 | SmartBrief

After a meeting with the FDA, Capricor Therapeutics said it will proceed with development of CAP-1002 to treat Duchenne muscu -More

Original Article: Capricor to continue trials of DMD treatment

NEXT ARTICLE

More From BioPortfolio on "Capricor to continue trials of DMD treatment"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...